Our study not only confirmed that luteolin inhibits the proliferation of NPC CNE2 cells in vitro and promotes apoptosis of CNE2 cells through the PI3K-AKT signaling pathway but also showed that the common drug-disease targets. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.